A Gene Expression Signature for RSV: Clinical Implications and Limitations

PLoS Medicine

Volumn 10, Issue 11, 2013, Pages

  Openshaw, Peter J M ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; PALIVIZUMAB;

ARTICLE; BRONCHIOLITIS; DEATH; DISEASE SEVERITY; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INFLUENZA; MORBIDITY; MORTALITY; NONHUMAN; PNEUMOVIRUS INFECTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS INFECTION; RESPIRATORY TRACT INFECTION; RNA ANALYSIS; VACCINATION; VIRAL CLEARANCE; VIRUS PATHOGENESIS;

HUMANS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RNA; SEVERITY OF ILLNESS INDEX; TRANSCRIPTOME;

EID: 84889037384     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001550     Document Type: Article

References (12)

1. Nair H, Simoes EA, Rudan I, Gessner BD, Azziz-Baumgartner E, et al. (2013) Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis. Lancet 381: 1380-1390.
2. Openshaw PJ, Chiu C, (2013) Protective and dysregulated T cell immunity in RSV infection. Curr Opin Virol 3: 468-474.
3. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, et al. (2010) Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375: 1545-1555.
4. Falsey AR, (2007) Respiratory syncytial virus infection in adults. Semin Respir Crit Care Med 28: 171-181.
5. Lee N, Lui GC, Wong KT, Li TC, Tse EC, et al. (2013) High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. Clin Infect Dis 57: 1069-1077.
6. Blanken MO, Rovers MM, Molenaar JM, Winkler-Seinstra PL, Meijer A, Kimpen JL, et al. (2013) Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med 368: 1791-1799.
7. Turchinovich A, Samatov TR, Tonevitsky AG, Burwinkel B, (2013) Circulating miRNAs: cell-cell communication function? Front Genet 4: 119.
8. McNamara PS, Flanagan BF, Baldwin LM, Newland P, Hart CA, et al. (2004) Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis. Lancet 363: 1031-1037.
9. Janssen R, Bont L, Siezen CL, Hodemaekers HM, Ermers MJ, et al. (2007) Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. J Infect Dis 196: 826-834.
10. Welliver TP, Garofalo RP, Hosakote Y, Hintz KH, Avendano L, et al. (2007) Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis 195: 1126-1136.
11. Kristjansson S, Bjarnarson SP, Wennergren G, Palsdottir AH, Arnadottir T, et al. (2005) Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response. J Allergy Clin Immunol 116: 805-811.
12. Munir S, Hillyer P, Le NC, Buchholz UJ, Rabin RL, et al. (2011) Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response. PLoS Pathog 7: e1001336 doi:10.1371/journal.ppat.1001336.